Goodwill (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Goodwill [Line Items] | ||||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | ||
| Balance at the beginning | $ 1,278,452,778 | $ 3,805,628 | $ 1,309,750,216 | $ 871,128 | $ 1,309,750,216 | $ 871,128 | $ 871,128 | $ 741,128 | ||||
| Impairment charges | 0 | $ 851,455,754 | $ 0 | 851,455,754 | $ 0 | 0 | 0 | $ 0 | ||||
| Balance at the end | $ 1,309,750,216 | 1,309,750,216 | $ 1,309,750,216 | $ 458,294,462 | 458,294,462 | 3,805,628 | 871,128 | $ 741,128 | ||||
| Acquisitions | $ 31,297,438 | $ 0 | $ 2,934,500 | $ 130,000 | ||||||||
| Term of steady decline in share price | 3 months | |||||||||||
| Percentage of stock lower than opening price | 63.00% | |||||||||||
| X | ||||||||||
- Definition Percentage of stock lower than opening price. No definition available.
|
| X | ||||||||||
- Definition Term of steady decline in share price. No definition available.
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|